|
TENX Tenax Therapeutics Inc 34956 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-17,803,000.00 |
| Balance Sheet |
|
Current Assets
|
$121,663,000.00 |
|
Assets
|
$121,663,000.00 |
|
Current Liabilities
|
$8,073,000.00 |
|
Liabilities
|
$8,073,000.00 |
|
Equity
|
$113,590,000.00 |
|
Shares Out
|
31949785.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,459,000.00 |
| Market Analysis |
Market Cap
|
$56,870,617.30 |
|
Price
|
$1.78 |
|
BVPS
|
3.56 |
|
PB
|
0.50 |
|
EPS
|
-0.35 |
|
FCF
|
$-23,461,843.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:34 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TENX documents filed with the SEC.
TENX Filings
Clear
